Maze Therapeutics, Inc. Common Stock
MAZE
$26.21-6.69%
End of day · as of Sep 25, 2026, 1:00 AM ET
Mkt cap
$525.32M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-03-31)
$20.00M
EPS (H1 2026)
$-1.00
Gross Margin (qtr ended 2026-03-31)
N/A
Profit Margin (qtr ended 2026-03-31)
-121.04%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported MAZE revenue for 2026-03-31 was $20.0M. Net income was -$24.2M. MAZE currently screens at market cap $525.3M.
Use this MAZE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MAZE income, balance, and cash tables.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company in the Healthcare sector.
Latest cached Maze Therapeutics, Inc. Common Stock (MAZE) revenue for Mar 31, 2026 was $20.0M. Net income was -$24.2M. Statements: https://lician.com/financials/maze
Maze Therapeutics, Inc. Common Stock (MAZE) market capitalization is $525.3M on the latest cached snapshot.
Maze Therapeutics, Inc. Common Stock (MAZE) cached previous close $28.09; day range $25.96 – $28.46; volume 788,971. Session quote: https://lician.com/quote/maze
Maze Therapeutics, Inc. Common Stock (MAZE) latest cached earnings event is "MAZE earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MAZE filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/maze